Contact
0
Glass.Mapper.Sc.Fields.Image
Please note our Product Finder does not contain our complete product portfolio. Should you wish for further information on a specific product, please contact us.
Contact customer care
Know the product you're looking for?
Search products

Press center

Results from 1 to 5 on 90
Roquette Invests in DAIZ, an Innovative Japanese Food Tech Startup
Roquette Invests in DAIZ, an Innovative Japanese Food Tech Startup
This partnership is one more step towards Roquette’s vision of tastier and healthier plant-based ingredients that respond to global consumers’ expectations.
CPHI 2022: Roquette Launches Next-Generation Direct Compression Solutions
CPHI 2022: Roquette Launches Next-Generation Direct Compression Solutions
Join the Roquette team on stand 80C90 (Excipient Gold area) at CPHI in Frankfurt, Germany, to discover the latest innovations in direct compression technology, designed to overcome unique drug formulation challenges and support expansion into novel application areas.
Roquette Launches a New Line of Organic Pea Ingredients to Address Consumer Demand
Roquette Launches a New Line of Organic Pea Ingredients to Address Consumer Demand
Roquette reinforces its leadership position in the food revolution.
Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
Following its purchase of a majority share in the company in 2018, this latest move allows Roquette to continue realizing its strong growth ambitions and meet rising global demand for high-quality plant-based excipients.
Roquette expands PEARLITOL® SD mannitol range for highly sensitive active pharmaceutical ingredients (APIs)
Roquette expands PEARLITOL® SD mannitol range for highly sensitive active pharmaceutical ingredients (APIs)
Developed specifically for active pharmaceutical ingredients (APIs) that are highly sensitive to reducing sugars, PEARLITOL® 150 SD supports opportunities to unlock advanced tablet dosage forms – even when using challenging active ingredients.